|
Market Closed -
Nasdaq
00:00:00 27/10/2026 +04
|
5-day change | 1st Jan Change | ||
| 6.470 USD | -0.46% |
|
+2.86% | -46.71% |
| 10-24 | Ocular Therapeutix, Inc. - Special Call | |
| 10-20 | Ocular Therapeutix Has 75% Success Probability for Axpaxli in Wet Age-Related Macular Degeneration, UBS Says | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| OCULAR THERAPEUTIX, INC. | Other Pharmaceuticals | -0.46% | +2.86% | -46.71% | -43.69% | -8.87% | 1.42B |  | | |
- Stock Market
- Stocks
- OCUL Stock
- Charts Ocular Therapeutix, Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
